According to @mcuban, the plan would 1) price brand drugs at net after rebates and fees during the deductible phase for all plans, which he says would save patients tens of billions, source: @mcuban on X, Nov 9, 2025. He also proposes 2) requiring intercompany transfers from owned providers at Medicare rates to end gaming of medical loss ratios, source: @mcuban on X, Nov 9, 2025. He adds 3) partnering with providers to guarantee all deductibles for ACA members who accept Medicare rates, aiming to reduce provider bad debt, end medical debt under the ACA, and boost plan utilization, source: @mcuban on X, Nov 9, 2025. He further recommends 4) mandating that any cash purchases apply to deductibles to enable price shopping, source: @mcuban on X, Nov 9, 2025. He concludes with 5) creating a national rebate group purchasing organization that all states join by default to negotiate brand and specialty drug rebates, source: @mcuban on X, Nov 9, 2025. He characterizes the package as a game changer for insurance and suggests expanding the model to uninsured care with means-tested repayments and a reinsurance cap if the numbers work, source: @mcuban on X, Nov 9, 2025. For trading, the measures target rebates, MLRs, Medicare-rate reimbursement, and deductible design that directly involve PBMs, health insurers, providers, and brand or specialty pharma, with no crypto or digital asset elements stated, source: @mcuban on X, Nov 9, 2025.